Skip to content
Sunday, November 8, 2026
Platinum Reels Point

The Zimbabwean Government Rejects ‘Lopsided’ US Healthcare Assistance Agreement Over Information Fears

Health funding image
The offered US funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a major US health deal valued at 367 million US dollars (£272m) spanning five years over the United States' request for sensitive data.

The decision became public after a government memo from December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "unbalanced".

An official spokesman has since stated that the US was demanding access to biological samples for scientific study and commercial gain while was unwilling to guarantee the benefits from future treatments.

"We are forced to start the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged continued dialogue to secure a agreement agreeable to both sides so the nation's critical HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision comes after a similar case in Kenya, where a high court suspended a similar deal with the US after concerns were raised about the security of Kenyans' medical information.

Since resuming office last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

The agency had administered assistance for the US government, but Trump stated its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.

According to statements, 16 African countries have so far signed these new health pacts, constituting more than $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to share its biological resources and data indefinitely, with no equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," Mangwana explained.

"In essence, our nation would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our people if a new disease outbreak emerge."

National Interest and International Frameworks

Mangwana further noted that the American exit from the global health body and its push of bilateral health agreements were disrupting structures previously established via the global organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.

"This system is designed to ensure that when a country contributes its data, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how subsequent co-operation might be arranged in a manner that honours the independence and dignity of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but urged that talks should continue given that much of the country's Aids initiatives relied on external financing.

"Where technical issues exist, including those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," the group commented.

This impasse underscores the complex challenges between accepting much-needed international aid and safeguarding a country's data in an ever more data-driven world.

About the author

Beverly Davis

A seasoned casino analyst with over a decade of experience in reviewing slot games and uncovering the best bonus deals for players worldwide.

Platinum Reels Point

Type to search articles.